Aurobindo Pharma Ltd on Monday said its Anti-retro viral products have been included in World Health Organisation's pre-qualification list.
The company has received the tentative approval from the US Food & Drug Administration to manufacture and market these combination tablets in strengths of 600mg/300mg/ 300mg, a statement by Aurobindo Pharma said.
RBI's fifth bi-monthly monetary policy meet due tomorrow also kept the investors on their toes.
